Knowstox

Fundamentals snapshot

Aehr Test Systems, Inc.

AEHR · NCM · Technology · Semiconductor Equipment & Materials

Current price

$96.93

52-week range

$18.70 - $147.40

Market cap

$3.17B

One-glance verdict

Overvalued

$4.35 our estimate vs market $96.93

Wall Street consensus: $128.00 (2,839.6% higher than our fair-value estimate)

Balance sheet

Healthy

-10.39x Concerning

Net cash $106.48M. Interest coverage shows how many times profit covers the interest bill.

What this company does

Aehr Test Systems, Inc.

Aehr Test Systems sells specialized machines that stress-test computer chips to ensure they work reliably before they are put into products like electric cars and smartphones. The company's main business comes from selling these systems to chipmakers, especially for a new type of chip called silicon carbide which is critical for the growing electric vehicle industry. This positions Aehr as a key supplier to a major technology trend.

Price history

How the share price has moved

Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2025 Q1 $2.18M FY2025 Q2 $-6.19M FY2025 Q3 $-3.26M FY2025 Q4 $-5.12M FY2026 Q1 $-1.67M FY2026 Q2 $-1.64M FY2026 Q3 $-3.76M FY2026 Q4 $1.70M
Revenue $18.84M
Net income $1.39M
Diluted EPS 0.05
Operating cash flow $1.83M
Free cash flow $1.70M
Revenue $10.31M
Net income $-3.20M
Diluted EPS -0.10
Operating cash flow $-3.69M
Free cash flow $-3.76M
Revenue $9.88M
Net income $-3.23M
Diluted EPS -0.11
Operating cash flow $-1.17M
Free cash flow $-1.64M
Revenue $10.97M
Net income $-2.08M
Diluted EPS -0.07
Operating cash flow $-282.00K
Free cash flow $-1.67M
Revenue $14.09M
Net income $-2.90M
Diluted EPS -0.10
Operating cash flow $-2.30M
Free cash flow $-5.12M
Revenue $18.31M
Net income $-643.00K
Diluted EPS -0.02
Operating cash flow $-1.60M
Free cash flow $-3.26M
Revenue $13.45M
Net income $-1.03M
Diluted EPS -0.03
Operating cash flow $-5.87M
Free cash flow $-6.19M
Revenue $13.12M
Net income $660.00K
Diluted EPS 0.02
Operating cash flow $2.38M
Free cash flow $2.18M

Is it cheap or expensive?

Fair value $4.35 vs current price $96.93

Wall Street consensus is the average analyst price target: $128.00 (2,839.6% higher than our fair-value estimate).

Our most-likely fair value is $4.35 a share — about 95.5% below today's price of $96.93, so the stock currently looks expensive (overvalued).

overvalued

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 25.0% · Discount 12.7% · Terminal 3.0%

$4.35

Bear

Growth 15.0% · Discount 12.7% · Terminal 3.0%

$3.92

Bull

Growth 25.0% · Discount 12.7% · Terminal 3.0%

$4.35

Is it drowning in debt?

Healthy

Net cash $106.5M - more cash than debt. Interest coverage -10.4x.

Net debt $-106.48M
Interest coverage -10.39x

Aehr Test Systems, Inc.'s profit covers its interest bill about 0.0 times over. which is weaker than most peers shown here and 2 peers sit below 1x, which is the danger zone where profit does not fully cover the interest bill.

Healthy
Worse cushion Baseline Better cushion
AEHR BASELINE Aehr Test Systems, Inc.

Total debt $9.88M Interest coverage -10.39x This is the baseline the peer rows are being compared against.

Total debt $331.24M Interest coverage -29.03x Neither company has much profit cushion over interest right now.

Total debt $29.91M Interest coverage 115.35x This peer still has a real interest-payment cushion, while AEHR does not.

Total debt $2.67B Interest coverage 6.20x This peer still has a real interest-payment cushion, while AEHR does not.

Total debt $38.12M Interest coverage -293.99x Neither company has much profit cushion over interest right now.

Total debt $1.47B Interest coverage 4.33x This peer still has a real interest-payment cushion, while AEHR does not.

What you should know

The case for and against AEHR

1 Reward 2 Risks

Rewards

  • Free cash flow was positive in 3/10 years.

Risks

  • Operating margin compressed from 20.6% to -6.4% over 3 years.
  • Return on equity was -4.2% last year — the company lost money on shareholders' equity.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
Forward P/E
70.07x
P/B
14.34x
P/S
63.31x
EV/EBITDA
-269.34x
PEG ratio
0.88x

Profitability

How much profit each dollar creates

Gross margin
35.3%
Operating margin
-6.4%
Net margin
-14.3%
ROE
-4.2%
ROA
-4.5%

Health

Liquidity and balance-sheet strength

Debt / equity
0.05x
Current ratio
10.33x
Quick ratio
7.60x
Total debt
$9.88M
Total cash
$116.36M

Growth

How the business has been compounding

Revenue TTM
$50.00M
Revenue 5Y CAGR
-0.4%
EPS TTM
-0.23
EPS 5Y CAGR

Cash flow

How much cash the business throws off

Operating CF TTM
$-3.31M
Free CF TTM
$-5.38M
FCF margin
-10.8%

Dividend

Shareholder payout

Yield
Payout ratio
0.0%
Last ex-div date